Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoporosis--an update

G Samsioe1

  • 1Department of Obstetrics and Gynecology, Lund University Hospital, Sweden.

Acta Obstetricia Et Gynecologica Scandinavica
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Osteoporosis is a growing global health issue, particularly fractures in women. Hormone replacement therapy (HRT) and estrogen replacement therapy (ERT) show promise in reducing fracture risk, even when initiated years after menopause.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased blood cadmium levels were not associated with increased fracture risk but with increased total mortality in women: the Malmö Diet and Cancer Study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

Optimal tolerability of ultra-low-dose continuous combined 17beta-estradiol and norethisterone acetate: laboratory and safety results.

Climacteric : the journal of the International Menopause Society·2009
Same author

Sociodemographic risk factors of metabolic syndrome in middle-aged women: results from a population-based study of Swedish women, The Women's Health in the Lund Area (WHILA) Study.

Climacteric : the journal of the International Menopause Society·2008
Same author

Symptoms in peri- and postmenopausal women in relation to testosterone concentrations: data from The Women's Health in the Lund Area (WHILA) study.

Climacteric : the journal of the International Menopause Society·2008
Same author

Could androgens protect middle-aged women from cardiovascular events? A population-based study of Swedish women: The Women's Health in the Lund Area (WHILA) Study.

Climacteric : the journal of the International Menopause Society·2007
Same author

Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2007

Area of Science:

  • Gerontology
  • Endocrinology
  • Public Health

Background:

  • Osteoporosis and fractures represent a significant and escalating global health concern.
  • While prevalent in Europe, Asia experiences a higher rate of increase in osteoporosis cases.
  • Estrogen deficiency, particularly in postmenopausal women, is a key factor, though its role in very elderly individuals (over 85) warrants further investigation.

Purpose of the Study:

  • To review the current understanding of osteoporosis and fracture risk factors.
  • To evaluate the efficacy and long-term implications of various osteoporosis treatments, including hormone therapies.
  • To assess the cost-effectiveness and optimal timing for initiating hormone replacement therapy (HRT).

Main Methods:

  • Review of existing literature on osteoporosis prevalence, risk factors, and treatment modalities.

Related Experiment Videos

  • Analysis of data on the effectiveness of hormone replacement therapy (HRT) and estrogen replacement therapy (ERT) in preventing fractures.
  • Consideration of bone mass measurement techniques and their associated costs.

    • Main Results:

    • Bone mass is a critical factor in osteoporosis; accurate measurement techniques are available but costly.
    • Emerging pharmacologic regimens show potential for osteoporosis prevention and treatment, but require long-term data.
    • ERT and HRT can significantly reduce osteoporotic fracture risk in women, with effects persisting after discontinuation.
    • Starting HRT 15-20 years post-menopause may still offer fracture protection and be cost-effective.

    Conclusions:

    • Osteoporosis is a major health challenge with increasing incidence globally, especially in Asia.
    • Hormone replacement therapy (HRT) and estrogen replacement therapy (ERT) are effective in reducing fracture risk in women.
    • Strategic initiation of HRT post-menopause could be a viable and cost-effective approach for long-term fracture prevention.